These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7955798)

  • 1. Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers.
    Schwartz JB; Capili H; Wainer IW
    Clin Pharmacol Ther; 1994 Oct; 56(4):368-76. PubMed ID: 7955798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of age and gender on the stereoselective pharmacokinetics of verapamil.
    Sasaki M; Tateishi T; Ebihara A
    Clin Pharmacol Ther; 1993 Sep; 54(3):278-85. PubMed ID: 8375122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
    Abernethy DR; Wainer IW; Longstreth JA; Andrawis NS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):904-11. PubMed ID: 8355215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics.
    Schwartz JB; Capili H; Daugherty J
    Clin Pharmacol Ther; 1994 May; 55(5):509-17. PubMed ID: 8181195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.
    Schwartz JB; Troconiz IF; Verotta D; Liu S; Capili H
    J Pharmacol Exp Ther; 1993 May; 265(2):690-8. PubMed ID: 8496816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging alters verapamil elimination and dynamics: single dose and steady-state responses.
    Schwartz JB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):364-73. PubMed ID: 2213568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
    Gupta SK; Atkinson L; Tu T; Longstreth JA
    Br J Clin Pharmacol; 1995 Oct; 40(4):325-31. PubMed ID: 8554934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.
    Karim A; Piergies A
    Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Abernethy DR; Wainer IW; Anacleto AI
    Drug Metab Dispos; 2000 Jul; 28(7):760-5. PubMed ID: 10859149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of flurbiprofen in man: influence of stereochemistry and age.
    Patel BK; Jackson SH; Swift CG; Hutt AJ
    Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of controlled-release verapamil in healthy volunteers and patients with hypertension or angina.
    Gupta S; Modi NB; Sathyan G; Ho Pl PL; Aarons L
    Biopharm Drug Dispos; 2002 Jan; 23(1):17-31. PubMed ID: 11891670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model.
    Bhatti MM; Foster RT
    Biopharm Drug Dispos; 1997 Jul; 18(5):387-96. PubMed ID: 9210977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers.
    Tan SC; Patel BK; Jackson SH; Swift CG; Hutt AJ
    Br J Clin Pharmacol; 2003 Jun; 55(6):579-87. PubMed ID: 12814452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender influence the stereoselective pharmacokinetics of propranolol.
    Gilmore DA; Gal J; Gerber JG; Nies AS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Gorski JC; Wainer IW; Schwartz JB
    Clin Pharmacol Ther; 1999 Jul; 66(1):40-50. PubMed ID: 10430108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.